Financhill
Back

TC BioPharm (Holdings) PLC Vs. Adaptimmune Therapeutics PLC Industry Stock Comparison

Sell
10

TCBP
TC BioPharm (Holdings) PLC

Last Price:
1.12
Seasonality Move:
-52.74%
Sell
20

ADAP
Adaptimmune Therapeutics PLC

Last Price:
0.80
Seasonality Move:
35.83%
Sell
10
TC BioPharm (Holdings) PLC (TCBP) is a Sell

Is TC BioPharm (Holdings) PLC a Buy, Sell or Hold?

  • The current TC BioPharm (Holdings) PLC [TCBP] share price is $1.07. The Score for TCBP is 10, which is 80% below its historic median score of 50, and infers higher risk than normal.
  • TCBP is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
20
Adaptimmune Therapeutics PLC (ADAP) is a Sell

Is Adaptimmune Therapeutics PLC a Buy, Sell or Hold?

  • The current Adaptimmune Therapeutics PLC [ADAP] share price is $0.82. The Score for ADAP is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
  • ADAP is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

TCBP Stock Price Chart

What is TC BioPharm (Holdings) PLC's stock price today?

  • The TC BioPharm (Holdings) PLC share price today is $1.07
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and TCBP is experiencing slight selling pressure.

ADAP Stock Price Chart

What is Adaptimmune Therapeutics PLC's stock price today?

  • The Adaptimmune Therapeutics PLC share price today is $0.82
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ADAP is experiencing buying pressure, which is a positive indicator for future bullish movement.

TCBP Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.06 Sell
Relative Strength Index (14 RSI): 24.67 Sell
Chaikin Money Flow: -182689 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.11 - 4.61) Sell
Bollinger Bands (100): (3.19 - 8.03) Sell

ADAP Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.03 Sell
Relative Strength Index (14 RSI): 48.62 Sell
Chaikin Money Flow: 454670 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.75 - 0.87) Buy
Bollinger Bands (100): (0.86 - 1.2) Sell

TCBP Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.24 Sell
20-day SMA: 2.27 Sell
50-day SMA: 4.6 Sell
200-day SMA: 9.29 Sell
8-day EMA: 1.32 Sell
20-day EMA: 2.24 Sell
50-day EMA: 3.88 Sell
200-day EMA: 72.7 Sell

ADAP Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.8 Buy
20-day SMA: 0.8 Buy
50-day SMA: 0.92 Sell
200-day SMA: 1.13 Sell
8-day EMA: 0.8 Buy
20-day EMA: 0.81 Buy
50-day EMA: 0.9 Sell
200-day EMA: 1.03 Sell

TC BioPharm (Holdings) PLC Earnings Growth & TCBP Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Adaptimmune Therapeutics PLC Earnings Growth & ADAP Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.22 per share, and a decrease next year of $0.34 per share.

TC BioPharm (Holdings) PLC Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Adaptimmune Therapeutics PLC Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):